Effective partnership and in-country resource mobilization in Sudan for cVDPV2 outbreak response amid multiple emergencies in 2020–2021
Open Access
- 19 January 2024
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-8
Abstract
Background: During 2020 and immediately prior to the COVID-19 pandemic, Sudan was experiencing multiple emergencies including violence, seasonal flooding, and vector-borne disease outbreaks. After more than ten years since its last case of wild poliovirus, Sudan declared a circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak on 9 August 2020. Methods: cVDPV2 outbreak response data and programme documents of the Federal Ministry of Health and WHO were reviewed. Surveillance data was verified through WHO-recommended procedures for detecting and characterizing polioviruses from stool and sewage samples collected from acute flaccid paralysis (AFP) cases and the environment. Results: This outbreak in Sudan led to a total of 58 confirmed cases of cVDPV2 from 15 of the 18 states. Two nationwide vaccination campaigns were held to increase immunity of children under-five against poliovirus type 2. Funding challenges were overcome by intense additional resource mobilization from in-country sources. The funding gap was bridged from domestic resources (49%) sourced through GPEI partners, and in-country humanitarian funding mechanisms. Conclusions: During an outbreak response and challenge of funding shortfall, mobilizing in-country resources is possible through coordinated approaches, regular communication with partners, disaggregation of needs, and matching in-kind and financial support to fill gaps. A cVDPV2 outbreak requires a fast, resourced, and quality response to stop virus circulation.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in AfricaThe Lancet Infectious Diseases, 2022
- Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Lessons from the elimination of poliomyelitis in AfricaNature Reviews Immunology, 2021
- Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2019–2020MMWR. Morbidity and Mortality Weekly Report, 2021
- Poliovirus vaccine options: another step forwardThe Lancet, 2020
- Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccineScience, 2020
- Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine — Worldwide, 2016MMWR. Morbidity and Mortality Weekly Report, 2016
- Polio Eradication Is Just Over the Horizon: The Challenges of Global Resource MobilizationJournal of Health Communication, 2010
- Wild poliovirus type 1 and type 3 importations--15 countries, Africa, 2008-2009.2009
- Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After EradicationRisk Analysis, 2006